G. Michael Flannigan

Rigid versus Flexible Cystoscopy A Controlled Trial of Patient Tolerance

G. Michael Flannigan, J. Gelister, J. Gareth Noble et al. · British Journal of Urology · 1988 · 61 citations

A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9

Guzanfar A. Choudry, P A Hamilton Stewart, John A. Double et al. · British Journal of Cancer · 2001 · 52 citations · Full text

Randomised, Placebo Controlled, Double Blind Study of Alfuzosin SR in Patients Undergoing Trial without Catheter Following Acute Urinary Retention

Tariq Shah, Victor Palit, Shekhar Biyani et al. · European Urology · 2002 · 41 citations

Urological Research, Urology, Double Blind Study +7

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy

Saurajyoti Basu, John E. Brown, G. Michael Flannigan et al. · International Journal of Cancer · 2004 · 27 citations · Full text

lndomethacin—an Alternative to Pethidine in Ureteric Colic

G. Michael Flannigan, RANDALL CLIFFORD, R.A. Carver et al. · British Journal of Urology · 1983 · 27 citations

Pain Medicine, Gastrointestinal Pharmacology, Pharmacotherapy +19